With a combined revenue of $21 trillion and $2.1 trillion in profits, the 2026 Fortune 500 is the definitive list of America's largest companies.

Fortune 500

AI is a major force shaping this year’s list—but it’s far from the only story.

World's Most Admired Companies

Almost $20 trillion in revenue—and a record-breaking $1.87 trillion in profits. Introducing the 2025 Fortune 500, the definitive list of the biggest companies in America.

Leaders in all industries rely more than ever on Big Tech—and appreciate the giants that deliver, at scale, without drama.

Industries included in the sector are banks, insurance, and real estate companies.

Fortune Sector Leaders: Financials

The Fortune 500, in its 70th year in 2024, ranks the biggest U.S. companies by revenue.

The 26th edition of the list shows how much esteem Big Tech giants command among other business leaders.

The 25th Fortune World’s Most Admired Companies list suggests that tech giants’ peers respect them as much as ever.

The Fortune 500, in its 69th year in 2023, ranks the biggest U.S. companies by revenue.

Just as it dominates our economy, Big Tech now dominates Fortune’s annual ranking of corporate reputation.

This year’s Fortune 500 marks the 68th running of the list.

After a year in which humanity leaned more heavily than ever on tech giants, see which companies topped Fortune's ranking of corporate reputation.

This year’s Fortune 500 marks the 67th running of the list.

F500-2021-131-Aflac

The insurance company is the largest provider of supplemental insurance in the U.S. and is best known for its payroll deduction coverage.

For an astounding 13th straight year, Apple claims the top spot in Fortune’s annual ranking of corporate reputation, based on a survey of almost 3,800 executives, directors, and analysts.

This year's Fortune 500 marks the 66th running of the list.

F500-2020-146-Aflac

The supplemental health and life insurance provider is based in Columbus, Ga., and has a large business segment in Japan.

Here are the World's Most Admired Companies for 2019 as ranked in their industries. See who made the list.

This year's Fortune 500 marks the 65th running of the list.

Here are the World's Most Admired Companies for 2018 as ranked in their industries. See who made the list.

Our 2018 list of the 100 best companies as ranked by their employees. See which companies made the list.

Fortune 100 Best Companies to Work For

This year's Fortune 500 marks the 64th running of the list.

Here are the World's Most Admired Companies for 2017 as ranked in their industries. See who made the list.

Our 2017 list of the 100 best companies as ranked by their employees. See which companies made the list.

This year's Fortune Global 500 generated $27.7 trillion in revenues and $1.5 trillion in profits.

Fortune Global 500

This year's Fortune 500 marks the 63rd running of the list.

We surveyed tens of thousands of young employees to create this list of millennials’ favorite workplaces.

best workplaces for millennials 2017 Aflac

Employees say: 
 
&nbsp; 
 
"One of the best things about this company is the culture of honesty and transparency. If things are trending badly, we know about it and we know the plans that are in place to correct course. Everyone buys into the plan and executes together, as a team. When things are going great, we celebrate wins as a team. It's a great atmosphere—a competitive, winning atmosphere that I'm proud to be a part of." 
 
&nbsp; 
 
"I feel that this is a great place to work mainly because this company gives me opportunities to make a difference while at work. I have gotten the opportunity to be part of the Aflac cancer committee and raise money for Aflac's cancer center in Atlanta. The trip to Atlanta was one of the most meaningful things I have done at work. It is nice to put in everyday work for a company that cares, and it is even better to get to directly contribute and be supported by management." 
 
&nbsp;

100 Best Large Workplaces for Millennials

Here are the World's Most Admired Companies for 2016 as ranked in their industries. See who made the list.

Google/Alphabet is the No. 1 place to work for the seventh time in 10 years. Six newcomers include Veterans United at No. 30, Hilton Hotels at No. 56, and Slalom Consulting at No. 100. IKEA’s U.S. arm returns to the list, along with GoDaddy and Sheetz.

This year's Fortune 500 marks the 62nd running of the list.

Fortune’s second annual list of the 100 Best Workplaces for Women highlights companies with generous benefits, flexible schedules, and an emphasis on balancing work and life. 

100 best workplaces for women 2016- aflac

Employees say: 
&nbsp; 
"Aflac actually makes exceptions to our processes based on specific situations. The work environment is friendly and flexible. There is always something to do. I can go to management if my situation is not being addressed as I feel it should. I am treated as an individual when needed. The teams function as a family. We all work together to support the Aflac brand!! We are family!" 
&nbsp; 
"[I appreciate] the encouragement of work/life balance,and that family and personal health is allowed to come first. Also, the ability of management to see their employees' skill sets and to develop them in the professional direction they would fit best, even if it means going outside their current department." 
&nbsp; 
Read the Great Place to Work review .

100 Best Large Workplaces for Women

The second annual ranking of the best employers for workers 35 and under.

best workplaces for millennials 2016- Aflac

"I love how management is very approachable and attentive to what suggestions you may have. They try to implement them as best they can. I love how the company gives incentives just for being an Aflac employee, such as getting movies tickets at a discount, having valet dry cleaning services, etc. I love how when you go the extra mile you are noticed for it. I just love feeling appreciated and valued. I love Aflac!" says one millennial worker. 
 
&nbsp; 
 
According to another millennial: "Aflac is an amazing place to work. The culture here is like no other. Leadership truly cares about the people, and in turn the people take care of the business." 
 
&nbsp; 
 
Read the .

Business insiders have spoken: Asked which companies they most admire, more than 4,100 executives, directors, and analysts chose these top 50 All-Stars.

This year’s list marks Fortune's 18th year of partnering with Great Place to Work. Google ranks No.1 for the sixth time, and 16 new companies make impressive debuts, including Acuity (No. 3), Twitter (No. 24), and Riot Games (No. 13).

This year's Fortune 500 marks the 61st running of the list. Wal-Mart claims the top spot again. See who made the list.

The inaugural list of the 100 Best Workplaces for Millennials from our partners at Great Place to Work includes surprising newcomer Power Home Remodeling, making an impressive debut at No. 1. Other standouts include Chili’s Grill and Bar (no. 11), Elevation Church (No. 34), and Yelp (No. 41).

BEST COMPANIES 2015  Aflac

Occupying slot number 132 on the Fortune 500 list, Aflac spreads its wings far and wide as one of the nation’s largest insurers. But that doesn’t keep the company from feeling intimate. In addition to a “spot awards” program that recognizes outstanding employee achievements with instant cash, company stock and swag, the company holds a weeklong celebration for its staff every year. The event has included ice skating, mini-golfing, family outings, and more. That’s not all—those who volunteer at or help plan the affair also get invited to a party at CEO Dan Amos’ country farm. As one worker gushes, “We are made to feel special and appreciated.” <a style="color:#ff0000;" href="http://us.greatrated.com/aflac-inc" target="_blank">Read the Great Place to Work review.</a>

Google tops the list once again, marking its eighth appearance and fifth time as No. 1.

Global business is back. After limping through a worldwide financial crisis and economic slowdown, the 500 largest companies ranked by revenues shattered all sorts of performance records in 2013: They racked up combined revenues of $31.1 trillion, up 2.5% from 2012, and profits soared 27% to nearly $2 trillion. China’s 95 companies (up from 89 last year) posted $5.8 trillion in revenues. The U.S. has four fewer companies on the list than last year but remains (for now) the country leader, with 128 corporations on the list—including No. 1 Wal-Mart Stores—reporting $8.6 trillion in revenues. 

Wal-Mart stayed on top as its sales crept closer to half-a-trillion dollars. Apple moved into the top five. And UnitedHealth Group continued its steady climb. 

Key Financials (last Fiscal Year)

Revenues ($M)

Profits ($M)

Assets ($M)

Total Stockholder Equity ($M)

Profit Ratios

Profit as % of Revenues

Profits as % of Assets

Profits as % of Stockholder Equity

Perks

100% health coverage

Unlimited sick days

Telecommuting

Job sharing

Subsidized childcare

Compressed work weeks

Fully-paid sabbaticals

On-site fitness/subsidized gym

On-site medical care facility

Non-discrimination policy includes sexual orientation

Health insurance for part-timers

Sick days for part-timers

College tuition reimbursement

Student loan debt repayment

Medical facility at all locations

Paid Time Off

PTO limit (days)

Compensation

Most common job (for salaried employee)

Hiring/staffing (past 12 Months)

Full-time and part-time job growth

# of job applicants

Avg. # of applicants per opening

FT voluntary turnover

Jobs filled internally

Jobs filled by referral

# New graduates hired

Company Info

Industry

Sector

HQ Location

Company Type

# Work Sites

U.S. Employees

Web Address

Best Companies

Best Companies Rank

Best Companies URL

Millennials In The Organization

# of millennial employees

Millennials as % of total workforce

Women In The Organization

% of Women in the Company

% of Women in Executive/Manager Positions

Current All-Star Rank

Previous All-Star Rank

Industry Rank

Previous Industry Rank

Overall Score

Innovation

People Management

Use of Corporate Assets

Social Responsibility

Quality of Management

Financial Soundness

Long-Term Investment Value

Quality of Products/Services

Global Competitiveness

Earnings Per Share (last Fiscal Year)

Earnings Per Share ($)

EPS % Change (from prior fiscal year)

EPS % Change (5 year annual rate)

EPS % Change (10 year annual rate)

Total Return

Total Return to Investors (last year)

Total Return to Investors (5 year, annualized)

Total Return to Investors (10 year, annualized)

Aflac is a leading provider of supplemental health and life insurance solutions. Through its two primary business segments—Aflac Japan and Aflac U.S.—the company delivers a comprehensive portfolio of products, including cancer, medical, nursing care, whole life, and specialized insurance offerings tailored to diverse market needs. Aflac’s distribution strategy leverages a multichannel network encompassing individual agents, corporate partners, banks, brokers, and independent associates, allowing for broad market reach. Established in 1955, the company is known for its innovative product development and commitment to helping clients manage health-related financial risks.

Q2 2026

Q1 2026

Q4 2025

Q2 2025

Q1 2025

Q4 2024

Aflac (AFL): Company Profile, Stock Price, News, Rankings

legacy

Aflac

aflac

Good day, and welcome to the Aflac Incorporated first quarter 2026 earnings call. I would now like to hand the call over to David Young, Senior Vice President of Capital Markets. Please go ahead.

Good morning, and welcome. Thank you for joining us for Aflac Incorporated's first quarter 2026 earnings call. This morning, Dan Amos, Chairman and Chief Executive Officer, Aflac Incorporated, will provide an overview of our results and operations in Japan and the United States. Then Max Brodén, Senior Executive Vice President and Chief Financial Officer, Aflac Incorporated, will provide more detail on this quarter's financial results, including our capital and liquidity. These topics are also addressed in the materials we posted with our earnings release, financial supplement, and quarterly CFO video update on investors.aflac.com. For Q&A today, we are also joined by Virgil Miller, President of Aflac Incorporated and Aflac U.S., Charles Lake, Chairman and Representative Director, President of Aflac International, Masatoshi Koide, President and Representative Director, Aflac Life Insurance Japan, and Bradley Dyslin, Global Chief Investment Officer, President of Aflac Global Investments.

Before we begin, some statements in this teleconference are forward-looking within the meaning of federal securities laws. Although we believe these statements are reasonable, we give no assurance that they will prove to be accurate because they are prospective in nature. Actual results could differ materially from those we discuss today. We encourage you to look at our annual report on Form 10-K for some of the various risk factors that could materially impact our results. As I mentioned earlier, the earnings release with reconciliations of certain non-U.S. GAAP measures and related earnings materials are available on investors.aflac.com. I'll now hand the call over to Dan. Dan?

Thank you, David, and good morning, everyone. We're glad you've joined us. Although we have just one quarter under our belt, the first quarter marked a good start to the year. Aflac Incorporated reported net earnings per diluted share of $1.98 and adjusted earnings per diluted share of $1.75. These results reflect our focused execution of our strategy, thus creating long-term value for our shareholders. Starting with Japan, as you will recall last year, Aflac Japan implemented a marketing and sales transformation which helped deliver the strong results and sales momentum we saw in 2025 and again in this quarter. This transformation was a major strategic initiative driven by Aflac Japan's corporate strategy and marketing and sales team.

I would highlight the leadership of Deputy President Shinsuke Morimoto, First Senior Vice President Michihiro Ito, and Chief Marketing Officer Yumi Saito, working together with Executive Vice President Yoshizumi to make it happen. As a cohesive management team, they delivered strong results. I'm excited about and innovation that they have produced and will continue to bring to the organization moving forward. With this in mind, I'm pleased with Aflac Japan's sales increase of a 25.5% increase for the first quarter. These strong sales results were driven largely by our newest medical product, Anshin Palette and Miraito, our latest cancer insurance product. As part of our ongoing strategy, we continue to emphasize and promote the importance of third sector protection to new and younger customers with our innovative first sector product, Tsumitasu.

The value of our policies resonates with millions of policyholders, and this reinforces how Aflac's overall strategy is effective and reputation is important. By maintaining strong persistency while adding new premium through sales, we seek to offset the impact of lapses and reissue, as well as policies reaching paid-up status in the future. Maintaining strong persistency continues to be important to the future of Aflac Japan. Our broad network of distribution channels, including agencies, alliance partners, and banks, continually leverage opportunities to help provide financial protection to Japanese consumers. For the quarter, all of our distribution channels generated increases in sales, which is significant considering that we prioritize being where the customer wants to buy insurance.

We will continue to evaluate the needs of each channel and support those needs as we work together to provide Japanese citizens with financial protection. Turning to Aflac U.S., I am encouraged by the 2.9% year-over-year increase in sales and the momentum we are seeing within all areas of our group business, especially our group voluntary products. More importantly, we maintain strong premium persistency of 79.3% and increased net earned premium of 3.5% for the quarter. We continue to focus on driving our profitable growth with strong underwriting discipline and maintaining strong premium persistency. We believe this will continue to drive net earned premium growth. At the same time, Aflac U.S. has continued its prudent approach to expense management and maintaining a strong pre-tax margin, as Max will expand upon shortly.

Across Japan and the United States, consumers are feeling the increasing burden of out-of-pocket medical expenses. That's where we step in. Our management teams, employees, and sales distribution partners are united to be there for the policyholders when they need us most. As the pioneer in cancer insurance and a leader in the industry, our team and sales partners show up every day to help ease the burden, providing financial protection with genuine compassion and care. As an insurance company, our primary responsibility is to fulfill the promises we make to the policyholders while being responsive to the needs of shareholders. We generated strong capital and cash flows on an ongoing basis while maintaining our commitment to prudent liquidity and capital management. We continue to be pleased with our investments, producing solid investment income.

Our financial strength is the foundation that backs up our promise to our policyholders, balanced with the financial flexibility and tactical capital deployment. I am very pleased with the company's financial strength, which supports our capital deployment. We treasure our 43 consecutive years of dividend increases and remain committed to extending this record. Combining share repurchase and dividends, we delivered $1.3 billion back to the shareholders in the first quarter. In doing so, we have maintained our position among companies with the highest return on capital and the lowest cost of capital in the industry. In today's complex healthcare environment, Aflac stands out as a trusted partner, combining relevant products, financial strength, a powerful brand, and broad distribution to help consumers manage the financial strain of out-of-pocket medical expenses.

The ongoing foundational strengths of our business and our capacity for continued growth in Japan and the United States, two of the largest life insurance markets in the world, support our leading position and build on our momentum. I will now turn the program over to Max to cover more details of the financial results. Max?

Thank you, Dan. For the first quarter of 2026, adjusted earnings per diluted share increased 6.6% year-over-year to $1.77, excluding effect of foreign currency in the quarter. In this quarter, remeasurement gains on reserves totaled $82 million, reducing benefits by $23 million or $0.04 per diluted share above plan. Variable investment income ran $14 million or $0.02 per diluted share below our long-term return expectations. Adjusted book value per share, excluding foreign currency remeasurement, increased 0.2%. The adjusted ROE was 12.8% and 16.4% excluding foreign currency remeasurement, a solid spread to our cost of capital. Overall, we view these results in the quarter as solid. Starting with our Japan segment, net earned premiums in yen terms for the quarter declined 3.8%.

Aflac Japan's underlying earned premiums, which excludes the impact of reinsurance, paid up policies, and deferred profit liability, declined 1.3%. We believe this metric provides a clearer insight into long-term premium trends. Japan's total benefit ratio came in at 62.9% for the quarter, down 290 basis points year-over-year. We estimate the impact from reserve remeasurement gains exceeding plan to be approximately 70 basis points. We continue to have favorable trends in cancer and hospitalization. While persistency was down, it remains strong and in line with our expectations at 92.8%. We continue to see an uptick in lapse and reissue on our cancer insurance product. Lapses on our first sector savings block remain low and in line with previous periods, despite the increase in yen interest rates.

Our expense ratio in Japan was 19.5% for the quarter, down 10 basis points year-over-year. For the quarter, adjusted net investment income in yen terms was up 4%, primarily driven by higher U.S. dollar fixed rate income on higher volume and higher variable net investment income compared to last year. Partially offset by lower dollar denominated floating rate income due to lower volume and rates, as well as reduced call income. The pre-tax margin for Japan in the quarter was 35%, up 320 basis points year-over-year, a very good result. Turning to U.S. results, net earned premiums were up 3.5%. Premium persistency remains solid at 79.3%.

Our total benefit ratio came in at 47.2%, 50 basis points lower than Q1 2025, driven by favorable incurred claims for individual voluntary benefits products and group disability. We estimate that reserve remeasurement gains impacted the benefit ratio by approximately 230 basis points in the quarter, which is about 80 basis points above plan. Our expense ratio in the U.S. was 38.3%, up 70 basis points year-over-year, primarily driven by higher DAC amortization and commissions, along with timing of advertising and investment spend. Adjusted net investment income in the U.S. was down 0.5% for the quarter, primarily driven by lower short-term rates offset by higher variable net investment income.

Profitability in the U.S. segment was solid with a pre-tax margin of 20.4%, a 40 basis points decrease compared with a strong quarter a year ago. Corporate and other reported break-even pre-tax adjusted earnings, down from a $43 million gain last year, driven by lower adjusted net investment income, higher interest expense and operating costs, and run-off impacts from closed blocks of business. Adjusted net investment income was $17 million lower than last year due to a combination of lower hedge benefits, partially offset by lower volume of tax credit investments. Our tax credit investments impacted the net investment income line for U.S. GAAP purposes negatively by $5 million in the quarter with an associated credit to the tax line. There were no benefit in first quarter earnings from tax credit investments. We're pleased with the overall performance of our investment portfolio.

During the quarter, we recorded $19 million of charge-offs on our loan portfolio. Additionally, we did not foreclose on any properties in the period. We recorded $24 million of impairments on our real estate owned portfolio to reflect the continued depressed valuations in the commercial real estate markets. However, we continue to believe that the current distressed market does not reflect the true intrinsic value of our portfolio, which is why we continue to manage them through this cycle and maximize our recoveries. For U.S. statutory, we recorded $12 million of impairments on invested assets and a $1 million valuation allowance on mortgage loans as an unrealized loss during the quarter.

On a Japan FSA basis, securities impairments reversals led to a net realized gain of JPY 66 million in Q1, and we booked a valuation allowance of JPY 201 million related to transitional real estate loans. This is well within our expectations and has limited impact on regulatory earnings and capital. Effective March 31st, Aflac Re Bermuda entered into a transaction in which it assumed a block of whole life annuities from Japan Post Insurance. This transaction itself is immaterial to Aflac Inc's financials, but it marks a strategic milestone as we expand our reinsurance franchise targeting the Japan market. Aflac Inc unencumbered liquidity stood at $3.4 billion, which was $2.4 billion above our minimum balance of $1 billion at the end of the quarter.

Our adjusted leverage was 21.2% for the quarter, which is within our target range of 20%-25%. As we hold approximately 65% of our debt in yen, this leverage ratio is impacted by moves in the yen dollar exchange rate. This is intentional and part of our enterprise hedging program, protecting the economic value of Aflac Japan in U.S. dollar terms. Our capital position remains strong. We ended the quarter with an estimated regulatory ESR of 227%. If including the undertaking specific parameter or USP, this would add 16 points to the regulatory ratio and result in an ESR with USP of 243%. We estimate our combined RBC to be approximately 560%.

These are strong capital ratios, which we actively monitor, stress, and manage to withstand market volatility and credit cycles, as well as external shocks. Given the strength of our capital and liquidity, we repurchased $1 billion of our own stock and paid dividends of $315 million in Q1, offering good relative IRR on these capital deployments. We will continue to be flexible and tactical in the way we manage the balance sheet and deploy capital in order to drive strong risk-adjusted ROE with a meaningful spread to our cost of capital. I will now turn the call back over to David.

Thank you, Max. Before we begin our Q&A, we ask that you please limit yourself to one initial question and a related follow-up. You may then rejoin the queue to ask additional questions. Our operator for today's call will now give you instructions on how to rejoin the queue and then announce our first question.

We will now begin the question-and-answer session. To ask a question, you may press star, then one on your telephone keypad. If you are using a speakerphone, you will need to pick up the handset before pressing the keys. To withdraw your question, please press star, then two. At this time, we will pause momentarily to assemble the roster. Our first question comes from Tom Gallagher of Evercore ISI. Please go ahead.

Morning. First question is just on capital generation. Max, can you talk about, can you help quantify how much benefit you got from that external reinsurance deal? Were there any ESR headwinds that emerged in Japan that might have impacted things?

The reinsurance transaction we executed in the first quarter with an external party, the impacts to capital were relatively small. This was a relatively small block in the scheme of compared to the overall enterprise. It wasn't really meaningful to either the ESR or FSA earnings in the quarter. In terms of the movements in the ESR, as you recall, we're down a little bit compared to the full year. The main driver of that is subsidiary dividends being moved up from Aflac Japan to the holding company in the quarter. Other than that, you have our sensitivities, and they work pretty well in terms of estimating the other impacts.

Obviously, higher yen rates has a slightly negative impact to the ESR because of the increased capital charge associated with mass lapse risk. At the same time, you also saw a little bit of a yen weakening that is benefiting the ESR. Relatively small impacts from capital markets inputs to the ESR.

Okay. Thanks for that. My follow-up is just, I think there was a change in the lapse and reissue activity during the quarter. Normally, it's much older policies, and it was less so this quarter. Can you talk about what does that mean from an IRR perspective for Aflac when there's somewhat younger customers that are doing lapse and reissue? Are those still positive IRRs when you think about, you know, your economics? Thanks.

Thank you, Tom. When you have a policy that is a little bit shorter in its duration because that policy is now lapsing and now moving into a new policy, what tends to happen in that scenario is, obviously, the policyholder is doing this for in order to get a better coverage. Once you have gotten that better coverage, you probably more likely to improve the persistency post the lapse and reissue activity. When you think overall, we think when we analyze this through the totality of the overall block, relatively minor impacts on the IRRs. There will be if you take a snapshot of one specific policy that just lapsed, obviously, that IRR is a little bit lower than originally assumed.

We now think about that new policy it is moving into, the duration of that policy is likely to be longer, and that might actually improve the IRR of that new policy that is being written. That is sort of working a little bit as a balancing impact. The overall impact to IRRs across the whole in-force is expected to be quite minor.

The next question comes from Ryan Krueger of KBW. Please go ahead.

Hey, thanks. Good morning. I had a question on the Japan benefit ratio. You know, it's towards the high end of your target in the quarter and a little bit above, I guess, excluding favorable experience. Can you just talk about the key drivers of expected improvement in the benefit ratio as the year goes on towards the 60%-63% outlook?

Yeah. Thank you, Ryan. When we think about the different drivers being underlying experience, that being the lower net premium ratio established in the third quarter of last year, and then also different types of lapse activity, we would expect going forward, the favorable experience that we did have in this quarter and we've had for a long time, we think that we will continue to generally have those trends in place. When we think about the net premium ratio, that has been set, more or less, and that's more driven by mix of business, as it relates to the current year benefit ratio. Obviously, we will update our net premium ratio with our long-term assumption unlock in the third quarter of this year.

The last piece being the mix of lapsation. We did have a mix in this quarter with a little bit less of old age cancer and a little bit higher lapsation of more recently issued policies. When that happens, you naturally have less of an impact on the reported GAAP benefit ratio. The younger policies have less of a reserve being built up relative to old policies. Especially old policies with a CSV could have quite an impact on the reported benefit ratio given the release of those reserves. As we then think about these impacts and trends running through our results for the full year, we still feel very confident with the outlook range that we gave at the beginning of the year of 60%-63% for the Japan benefit ratio.

Great. Thanks. You did, I know it was smaller as a starting point, on the first third party Japan reinsurance transaction, could you talk a little bit about how big of an opportunity you think that is for Aflac, I guess, over time? You know, could that move the needle some on your growth in Japan?

These transactions, while this one was a relatively small transaction, could be material to us over time. These can be pretty sizable blocks when executed, and they would then be immediately accretive to our earnings profile. Japan obviously is a very sizable market. I don't think that we will target the whole market. We will be selective in the way we approach it, both in terms of the target niches, and also the type of products and risks that we go after. It's obvious to us that we think that we have a balance sheet that is quite attractive for counterparties to transact with a double A rating. We think that we have a certain expertise in how to navigate and transact in the Japanese market.

We now built a platform that is ready to do so. We do think that adding also some risks, i.e., that being mortality, longevity risk, and spread risk to our balance sheet can be quite attractive to us from a risk management standpoint as well. There are many factors at play that makes this quite attractive from a financial standpoint for us. I think this will be, it will take time for this to build up. Over time, we certainly expect that this will be material to the company.

The next question comes from Wes Carmichael of Wells Fargo. Please go ahead.

Hey, thank you. Good morning. First question on Japan cancer sales, Miraito. Do you expect sales to sequentially improve in the next quarter, you know, relative to the first quarter? I know it's competing a bit now with the new medical product.

Medical cancer insurance Miraito's momentum is continuing, and we expect the 2026 sales to be equivalent to that of 2025.

We have created a system whereby the entire three products, starting with the cancer insurance Miraito, medical insurance Anshin Palette, and Tsumitasu to be sold concurrently.

Thank you. Appreciate that. Second question just was on the corporate segment. I know it was breakeven in the quarter, maybe a little bit of impact from tax credits, but, you know, it's bounced around a little bit. I was wondering, Max, is there any help you can give us with an expected run rate of earnings power there? I realize there's a few moving pieces.

Yeah. You tell me where short-term rates are gonna go, and I'll give you the answer, is a little bit of the, how this works. The main driver that is swinging our Corporate and Other segment around is the net investment income that we generate on our cash and liquid assets. Obviously, depending on how much capital we hold at the holdco times the short-term rates to some extent drives that. The other component to it is, this is where we hold our internal sorry, all our reinsurance treaties. Because these are runoff blocks, there's a natural decay, roughly about 8% per year.

That also drives down the earnings contribution year-over-year, unless we add and do more, either internal or external transactions adding to the earnings of that segment. As we go into Q2 right now, I would say that I would expect this segment to be slightly negative in terms of pre-tax earnings, given current volumes and rates and what we see from our reinsurance blocks.

Next question comes from Joel Hurwitz of Dowling & Partners. Please go ahead.

Hey, good morning. Max, wanted to go back to the external reinsurance transaction that you did with some of your first sector business in Japan. If I look at the seeded premiums and the tick up quarter-over-quarter, it looked like it had like a 1.5 point impact to net earned premium. Should we think that the earnings impact is similar to that premium impact over time or is there another way we should be thinking about earnings impact from that deal?

On that transaction, it negatively impacted our Aflac Japan earnings in the first quarter by a mid single digit U.S dollars in millions. That transaction or that block of business will initially have a negative impact along those lines for the next couple quarters. Over time it will go towards more of a zero impact. In the near term, we expect a negative earnings impact from that seeded business, and that it will go closer to zero over time as those policies reach paid up status.

Got it. That's helpful. Then switching to the U.S., there were some headlines in the past month that a state regulator was forcing rate cuts on some of your products. Are you seeing pressure from other states? Just how should we think about a potential impact to top line or earnings in the U.S.?

Hey, good morning, Joel. This is Virgil. No, we're not seeing any additional pressure like that. As a matter of fact, in the U.S., I'm pleased with how we are looking going forward with the year. We're still being consistent and balanced with our approach, but we're really seeing no material impacts at all.

The next question comes from Suneet Kamath of Jefferies. Please go ahead.

Great. Thank you. Good morning. Just wanted to start on strategy maybe with Dan. This reinsurance opportunity in Japan sounds interesting, but I guess another read could be sort of it's an indication that maybe the core business over there has less growth than maybe it previously did, and you're looking for other opportunities to sort of stimulate growth. Just curious, is that not the right read of this?

No, what I would say is that we're always looking for opportunities. We, you know, our position on reinsurance is we've taken a slow, methodical approach by starting by doing a reinsurance with another company. We ended up taking it internally, and what we've seen is success in the reinsurance business for us. Now the next thing is to do a deal with our biggest and closest partner, Japan Post. Then from there we'll see where it goes. We still believe there's a lot of opportunity to grow our business in Japan. This is a natural fit for us that we'll continue to watch. What I like is evolution, not revolution. We continue to methodically take this on and continue to grow the business.

Got it. Okay. I guess for Virgil, last quarter you gave us some good color in terms of the mix of sales, the group business versus kind of the core agent business. Just wondering if you could give us an update on what happened here in the first quarter and how you think things will trend for the balance of the year. Thanks.

Yes. Thank you. As mentioned to Dan, overall I'm pleased with the quarter. It's consistent, it's balanced. The color I gave on the group business, I'll give you some more insight, very similar. In the quarter, if you look at what we file as group products, that would include our dental and vision line, our core VB, and then you look at what we've been doing now with our group life and absence disability. If you add those three categories up, we're up about 12.4% for the quarter. What we've been calling by the bills, this is the investment we made with the dental and vision property. What we made, we were calling it PLAS, but let's just call it group life absence and disability.

With our direct to consumer platform that we refer to as consumer markets. When you add the three of those to those three entities up, the by the bills, we were up 25% for the quarter. Strong performance, very, very pleased with those. If you look at the dental and vision property, I fell on the sword, maybe a couple, over one year ago and told you that we were gonna invest in improving that business and get it back going. We're up 52% for the quarter. Strong performance. I believe that you'll continue to see solid performance in those categories. I am pleased with how we're trending.

Overall, you add in the point, the fact that we still have consistent strong persistency, 79.3%. That is how you're seeing though the overall increase in our premium income at 3.5%. If you look at the premium income, since the pandemic, we've seen steady increase and now, I'm pleased with where we're sitting with that metric.

Is the core business, like the agent business shrinking still, or what, like, what's going on with that piece?

Yeah. That, that's why you don't see the overall tremendous growth that you've seen in just the group space. That particular business, we've got some investments we're doing right now to try to get growth out of that business. What you're seeing right now is slightly down to flat. What's gonna improve that is our continued focus on in recruiting agents, and then making sure that we convert those agents. In the first quarter, we had a 60% conversion rate of new agents. That's where I continue to focus, and we continue to have strong productivity. The productivity with our agent group was about 8%. That's our continued focus. You're right, we're not seeing growth out of our core traditional business. We've also invested in improving and enhancing our enrollment process.

What that really means is we've made it easier for new agents to be onboarded and have given them tools where they can go out and sell quickly and get going. We all know that when you're in a market where you're having people come on that are getting paid commission, the best thing to do is get money in their hands as quickly as possible and get some accounts on the book. There's a metric that I monitor behind the scenes called new agent success, and what that really measures is can we get an agent to produce about $25,000 in the first three months and add three new accounts, and that metric is up also 8%. I think we're headed in the right direction.

With the market going toward group product and then group product continuing to go toward the smaller employee groups down now to 100 and some below 100 lives, we just have to continue to make sure that we are putting innovative product technology, and that's what we're investing in.

Aflac (AFL) Q1 2026 Earnings Call Transcript

Company Participants